Product Update Becton Dickinson Bonanno Suprapubic Catheter FST693 (ICN 2625)

• The discontinuation with Bonanno Suprapubic Catheter products from Becton Dickinson is now resolved.
• FST693 is no longer available to order and is in the process of being delisted from our online catalogue.
• This ICN is now closed.

• The discontinuation with Bonanno Suprapubic Catheter products from Becton Dickinson is continuing.
• FST693 is no longer subject to Protect Demand Management and is available to order without restrictions whilst our current stocks last.
• Once the stock is depleted the product will then be delisted from our online catalogue.
• The delisting is due to the supplier discontinuing the product and its production has now ceased.

Change:

• The supplier Becton Dickinson (BD) has informed us of a discontinuation with its Bonanno Suprapubic Catheter product.
• There is one product code affected:
  • FST693 – ­Catheter suprapubic with introducer needle.
• The supplier has chosen to discontinue the product and its production has now ceased.

Impact:          

• The affected code is available but is subject to Protect Demand Management.
• Once stock has depleted, FST693 will then be delisted from our online catalogue.
• See our Useful Links section to view resolved ICN 2583 for more information on the recent supply disruption and demand management.
• Potential indirect alternative products are available to order through our online catalogue.
• The BD Bonanno Suprapubic Catheter licenced use is solely for suprapubic catheter insertion, we recognise this product is used off licence as a chest drain.
• We have included alternatives for products for used for licenced purpose of suprapubic catheter insertion, and for common practice of chest drain insertion.
• See our Downloads ▼ section to access the product matrix below for further information on the affected product code and potential alternatives.

Next Steps:               

• Customers are advised to log into our website to view the potential indirect alternative products.
• Please note that due to the clinical nature of these alternative products we advise you to consult your own clinical experts to ensure suitability for your organisations use of these products.
• We will update this ICN prior to the product being delisted and, where applicable, update the product listing with additional alternatives.
• If you have any further questions, please contact your local NHS Supply Chain Customer Services Advisor.